AAAAAA
Results:
1-12
|
Results: 12
Authors:
BULPITT CJ
FLETCHER AE
DOSSEGGER L
NEISS A
NIELSEN T
VIERGUTZ S
Citation: Cj. Bulpitt et al., QUALITY-OF-LIFE IN CHRONIC HEART-FAILURE - CILAZAPRIL AND CAPTOPRIL VERSUS PLACEBO, HEART, 79(6), 1998, pp. 593-598
Authors:
ZANCHETTI A
BOND MG
HENNIG M
NEISS A
MANCIA G
DALPALU C
HANSSON L
MAGNANI B
RAHN KH
REID J
RODICIO J
SAFAR M
ECKES L
RAVINETTO R
Citation: A. Zanchetti et al., RISK-FACTORS ASSOCIATED WITH ALTERATIONS IN CAROTID-INTIMA-MEDIA THICKNESS IN HYPERTENSION - BASE-LINE DATA FROM THE EUROPEAN LACIDIPINE STUDY ON ATHEROSCLEROSIS, Journal of hypertension, 16(7), 1998, pp. 949-961
Authors:
KLEEMANN A
ECKERT S
VONECKARDSTEIN A
LEPPER W
SCHERNIKAU U
GLEICHMANN U
HANRATH P
FLECK E
NEISS A
ASSMANN G
BREITHARDT G
Citation: A. Kleemann et al., EFFECTS OF LOVASTATIN ON RESTENOSIS AFTER PTCA AND ON PROGRESSION OF CORONARY-ARTERY DISEASE - THE CHOLESTEROL-LOWERING ATHEROSCLEROSIS PTCA TRIAL (CLAPT), Journal of the American College of Cardiology, 29(2), 1997, pp. 3874-3874
Authors:
BESTEHORN HP
RENSING UFE
ROSKAMM H
BETZ P
BENESCH L
SCHEMEITAT K
BLUMCHEN G
CLAUS J
MATHES P
KAPPENBERGER L
WIELAND H
NEISS A
Citation: Hp. Bestehorn et al., THE EFFECT OF SIMVASTATIN ON PROGRESSION OF CORONARY-ARTERY DISEASE -THE MULTICENTER CORONARY INTERVENTION STUDY (CIS), European heart journal, 18(2), 1997, pp. 226-234
Authors:
KLEEMANN A
ECKERT S
VONECKARDSTEIN A
LEPPER W
SCHERNIKAU U
GLEICHMANN U
HANRATH P
FLECK E
NEISS A
ASSMANN G
BREITHARDT G
Citation: A. Kleemann et al., EFFECTS OF LOVASTATIN ON PROGRESSION OF CORONARY-ARTERY DISEASE AND RESTENOSIS AFTER PTCA - THE CHOLESTEROL-LOWERING ATHEROSCLEROSIS PTCA TRIAL (CLAPT), Atherosclerosis, 134(1-2), 1997, pp. 265-265
Authors:
SCHMITT HJ
VONKONIG CHW
NEISS A
BOGAERTS H
BOCK HL
SCHULTEWISSERMANN H
GAHR M
SCHULT R
FOLKENS JU
RAUH W
CLEMENS R
Citation: Hj. Schmitt et al., EFFICACY OF ACELLULAR PERTUSSIS-VACCINE IN EARLY-CHILDHOOD AFTER HOUSEHOLD EXPOSURE, JAMA, the journal of the American Medical Association, 275(1), 1996, pp. 37-41
Authors:
SCHMITT HJ
SCHUIND A
KNUF M
ZEPP F
BEUTEL K
VONKONIG CHW
NEISS A
BOCK HL
BOGAERTS H
CLEMENS R
Citation: Hj. Schmitt et al., ACELLULAR PERTUSSIS VACCINES - THE RATIONALE FOR AN EFFICACY TRIAL INGERMANY, The Journal of infectious diseases, 174, 1996, pp. 287-290
Authors:
ROSENTHAL J
BAHRMANN H
BENKERT K
BAUMGART P
BONNER G
KLEIN G
NEISS A
SCHNELLE K
FROHLICH ED
Citation: J. Rosenthal et al., ANALYSIS OF ADVERSE-EFFECTS AMONG PATIENTS WITH ESSENTIAL-HYPERTENSION RECEIVING AN ACE-INHIBITOR OR A BETA-BLOCKER, Cardiology, 87(5), 1996, pp. 409-414
Authors:
MESSERER D
NEISS A
HOROWITZ MM
HOELZER D
GALE RP
Citation: D. Messerer et al., COMPARISON OF CHEMOTHERAPY AND BONE-MARROW TRANSPLANTS USING 2 INDEPENDENT CLINICAL DATABASES, Journal of clinical epidemiology, 47(10), 1994, pp. 1119-1126
Authors:
SCHMITT HJ
JUST M
NEISS A
Citation: Hj. Schmitt et al., WITHDRAWAL OF A MUMPS VACCINE - REPLY, European journal of pediatrics, 153(6), 1994, pp. 467-468
Authors:
BOND G
DALPALU C
HANSSON L
MAGNANI B
MANCIA G
NEISS A
RAHN KH
REID JL
RODICIO JL
SAFAR M
ZANCHETTI A
Citation: G. Bond et al., THE ELSA TRIAL - PROTOCOL OF A RANDOMIZED TRIAL TO EXPLORE THE DIFFERENTIAL EFFECT OF ANTIHYPERTENSIVE DRUGS ON ATHEROSCLEROSIS IN HYPERTENSION, Journal of cardiovascular pharmacology, 23, 1994, pp. 85-87
Authors:
SCHMITT HJ
JUST M
NEISS A
Citation: Hj. Schmitt et al., WITHDRAWAL OF A MUMPS VACCINE - REASONS AND IMPACTS, European journal of pediatrics, 152(5), 1993, pp. 387-388
Risultati:
1-12
|